TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹85 Cr |
| Equity - Authorised | ₹210 Cr | ₹210 Cr | ₹210 Cr | ₹210 Cr | ₹125 Cr |
| Equity - Issued | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹85 Cr |
| Equity Paid Up | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹85 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹8,219 Cr | ₹7,421 Cr | ₹6,687 Cr | ₹6,029 Cr | ₹5,868 Cr |
| Securities Premium | - | - | - | - | ₹4.34 Cr |
| Capital Reserves | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr |
| Profit & Loss Account Balance | ₹5,724 Cr | ₹4,747 Cr | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr |
| General Reserves | ₹2,920 Cr | ₹2,884 Cr | ₹2,848 Cr | ₹2,813 Cr | ₹2,857 Cr |
| Other Reserves | ₹-430 Cr | ₹-215 Cr | ₹-109 Cr | ₹-93 Cr | ₹85 Cr |
| Reserve excluding Revaluation Reserve | ₹8,219 Cr | ₹7,421 Cr | ₹6,687 Cr | ₹6,029 Cr | ₹5,868 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹8,388 Cr | ₹7,591 Cr | ₹6,856 Cr | ₹6,198 Cr | ₹5,953 Cr |
| Minority Interest | ₹9,196 Cr | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹11,651 Cr | ₹1,192 Cr | ₹1,604 Cr | ₹2,496 Cr | ₹2,123 Cr |
| Non Convertible Debentures | ₹11,161 Cr | ₹643 Cr | ₹785 Cr | ₹1,273 Cr | ₹1,241 Cr |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹723 Cr | ₹1,133 Cr | ₹1,514 Cr | ₹1,926 Cr | ₹1,455 Cr |
| Term Loans - Institutions | - | - | - | ₹333 Cr | ₹400 Cr |
| Other Secured | ₹-233 Cr | ₹-584 Cr | ₹-696 Cr | ₹-1,036 Cr | ₹-972 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹4,972 Cr | ₹235 Cr | ₹101 Cr | ₹-142 Cr | ₹-300 Cr |
| Deferred Tax Assets | ₹922 Cr | ₹684 Cr | ₹960 Cr | ₹1,058 Cr | ₹1,206 Cr |
| Deferred Tax Liability | ₹5,894 Cr | ₹919 Cr | ₹1,060 Cr | ₹916 Cr | ₹906 Cr |
| Other Long Term Liabilities | ₹298 Cr | ₹160 Cr | ₹75 Cr | ₹75 Cr | ₹46 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹765 Cr | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr |
| Total Non-Current Liabilities | ₹17,686 Cr | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹2,358 Cr | ₹1,820 Cr | ₹2,089 Cr | ₹1,679 Cr | ₹1,674 Cr |
| Sundry Creditors | ₹2,358 Cr | ₹1,820 Cr | ₹2,089 Cr | ₹1,679 Cr | ₹1,674 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹2,451 Cr | ₹1,144 Cr | ₹1,130 Cr | ₹1,578 Cr | ₹1,365 Cr |
| Bank Overdraft / Short term credit | - | ₹47 Cr | ₹17 Cr | ₹46 Cr | ₹39 Cr |
| Advances received from customers | ₹27 Cr | ₹1.94 Cr | ₹4.50 Cr | ₹1.33 Cr | ₹10 Cr |
| Interest Accrued But Not Due | ₹183 Cr | ₹25 Cr | ₹38 Cr | ₹61 Cr | ₹35 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | ₹100 Cr | ₹243 Cr | ₹143 Cr | ₹488 Cr | ₹468 Cr |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹2,141 Cr | ₹826 Cr | ₹927 Cr | ₹982 Cr | ₹813 Cr |
| Short Term Borrowings | ₹2,915 Cr | ₹1,250 Cr | ₹1,638 Cr | ₹1,765 Cr | ₹923 Cr |
| Secured ST Loans repayable on Demands | ₹800 Cr | ₹450 Cr | ₹850 Cr | ₹998 Cr | ₹200 Cr |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹2,115 Cr | ₹800 Cr | ₹788 Cr | ₹767 Cr | ₹723 Cr |
| Short Term Provisions | ₹620 Cr | ₹504 Cr | ₹568 Cr | ₹425 Cr | ₹453 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹121 Cr | ₹96 Cr | ₹168 Cr | ₹31 Cr | ₹41 Cr |
| Provision for post retirement benefits | ₹4.15 Cr | ₹7.20 Cr | ₹3.43 Cr | ₹3.16 Cr | ₹2.90 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹495 Cr | ₹401 Cr | ₹397 Cr | ₹391 Cr | ₹408 Cr |
| Total Current Liabilities | ₹8,343 Cr | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr |
| Total Liabilities | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr |
| ASSETS | |||||
| Gross Block | ₹40,405 Cr | ₹14,041 Cr | ₹13,485 Cr | ₹12,812 Cr | ₹10,728 Cr |
| Less: Accumulated Depreciation | ₹7,227 Cr | ₹6,094 Cr | ₹5,346 Cr | ₹4,690 Cr | ₹4,306 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹33,178 Cr | ₹7,947 Cr | ₹8,138 Cr | ₹8,121 Cr | ₹6,423 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹457 Cr | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr |
| Non Current Investments | ₹83 Cr | ₹44 Cr | ₹32 Cr | ₹43 Cr | ₹42 Cr |
| Long Term Investment | ₹83 Cr | ₹44 Cr | ₹32 Cr | ₹43 Cr | ₹42 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹83 Cr | ₹44 Cr | ₹32 Cr | ₹43 Cr | ₹42 Cr |
| Long Term Loans & Advances | ₹281 Cr | ₹294 Cr | ₹349 Cr | ₹181 Cr | ₹167 Cr |
| Other Non Current Assets | ₹24 Cr | ₹10 Cr | ₹14 Cr | ₹28 Cr | ₹50 Cr |
| Total Non-Current Assets | ₹34,221 Cr | ₹8,773 Cr | ₹8,894 Cr | ₹9,139 Cr | ₹7,312 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹866 Cr | ₹112 Cr | ₹141 Cr | ₹156 Cr | ₹184 Cr |
| Quoted | ₹866 Cr | ₹112 Cr | ₹141 Cr | ₹156 Cr | ₹0.02 Cr |
| Unquoted | - | - | - | - | ₹184 Cr |
| Inventories | ₹3,138 Cr | ₹2,541 Cr | ₹2,279 Cr | ₹2,230 Cr | ₹2,462 Cr |
| Raw Materials | ₹840 Cr | ₹619 Cr | ₹630 Cr | ₹752 Cr | ₹841 Cr |
| Work-in Progress | ₹188 Cr | ₹167 Cr | ₹141 Cr | ₹116 Cr | ₹178 Cr |
| Finished Goods | ₹1,213 Cr | ₹1,105 Cr | ₹981 Cr | ₹860 Cr | ₹1,013 Cr |
| Packing Materials | ₹112 Cr | ₹62 Cr | ₹60 Cr | ₹57 Cr | ₹58 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹785 Cr | ₹588 Cr | ₹467 Cr | ₹444 Cr | ₹373 Cr |
| Sundry Debtors | ₹3,031 Cr | ₹1,866 Cr | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr |
| Debtors more than Six months | ₹91 Cr | ₹16 Cr | ₹19 Cr | ₹25 Cr | ₹12 Cr |
| Debtors Others | ₹2,999 Cr | ₹1,862 Cr | ₹1,836 Cr | ₹1,930 Cr | ₹1,628 Cr |
| Cash and Bank | ₹1,165 Cr | ₹579 Cr | ₹839 Cr | ₹571 Cr | ₹403 Cr |
| Cash in hand | ₹0.63 Cr | ₹0.54 Cr | ₹0.51 Cr | ₹0.37 Cr | ₹0.30 Cr |
| Balances at Bank | ₹1,165 Cr | ₹579 Cr | ₹839 Cr | ₹571 Cr | ₹403 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹404 Cr | ₹324 Cr | ₹328 Cr | ₹247 Cr | ₹332 Cr |
| Interest accrued on Investments | ₹25 Cr | ₹0.22 Cr | ₹0.29 Cr | ₹1.93 Cr | ₹0.05 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹98 Cr | ₹63 Cr | ₹59 Cr | ₹67 Cr | ₹51 Cr |
| Other current_assets | ₹281 Cr | ₹260 Cr | ₹269 Cr | ₹178 Cr | ₹280 Cr |
| Short Term Loans and Advances | ₹788 Cr | ₹200 Cr | ₹180 Cr | ₹166 Cr | ₹151 Cr |
| Advances recoverable in cash or in kind | ₹93 Cr | ₹71 Cr | ₹53 Cr | ₹58 Cr | ₹64 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹695 Cr | ₹129 Cr | ₹127 Cr | ₹107 Cr | ₹88 Cr |
| Total Current Assets | ₹9,392 Cr | ₹5,623 Cr | ₹5,611 Cr | ₹5,314 Cr | ₹5,165 Cr |
| Net Current Assets (Including Current Investments) | ₹1,049 Cr | ₹905 Cr | ₹186 Cr | ₹-134 Cr | ₹750 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr |
| Contingent Liabilities | ₹379 Cr | ₹156 Cr | ₹157 Cr | ₹151 Cr | ₹129 Cr |
| Total Debt | ₹14,798 Cr | ₹3,026 Cr | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr |
| Book Value | 247.84 | 224.27 | 202.57 | 183.13 | 351.75 |
| Adjusted Book Value | 247.84 | 224.27 | 202.57 | 183.13 | 175.87 |
Compare Balance Sheet of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹157,071.7 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
| MANKIND PHARMA | ₹102,844.0 Cr | 0.6% | 7.3% | 10.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.1% |
6.7% |
45.5% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses